Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ennis

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
British Medical Journal|September 12, 1970
Acid production in diabetic acidosis; a more rational approach to alkali replacementP Z Zimmet, P Taft, G C Ennis, et al.
Biochemical Society Transactions|May 1, 1993
WAY 100252 inhibits evoked [3H]GABA release when tested against a number of release-inducing stimuliJ Dunlop, C Ennis, J F White, et al.
Psychopharmacology|January 1, 1983
Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcementT W Robbins, B A Watson, M Gaskin, et al.
Physical Chemistry Chemical Physics : PCCP|September 8, 2018
The prediction of far-infrared spectra for planetary nitrile ices using periodic density functional theory with comparison to thin film experimentsC Ennis, R Auchettl, D R T Appadoo, et al.
Journal of Biotechnology|March 31, 2015
Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapyKrishnamurthy V Nemani, Riley C Ennis, Karl E Griswold, et al.
Journal of Neurochemistry|June 1, 1995
Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brainX Khawaja, N Evans, Y Reilly, et al.
Life Sciences|August 7, 1978
Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidoneJ M Van Nueten, C Ennis, L Helsen, et al.
Diseases (Basel, Switzerland)|October 26, 2021
Empowering Melatonin Therapeutics with <i>Drosophila</i> ModelsCassandra Millet-Boureima, Caroline C Ennis, Jurnee Jamison, et al.
Journal of Cardiovascular Pharmacology|April 1, 1989
Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitorC Ennis, S E Granger, V C Middlefell, et al.
Drugs|January 1, 1972
Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspectsH D Breidahl, G C Ennis, F I Martin, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
British Medical Journal|September 12, 1970
Acid production in diabetic acidosis; a more rational approach to alkali replacementP Z Zimmet, P Taft, G C Ennis, et al.
Biochemical Society Transactions|May 1, 1993
WAY 100252 inhibits evoked [3H]GABA release when tested against a number of release-inducing stimuliJ Dunlop, C Ennis, J F White, et al.
Psychopharmacology|January 1, 1983
Contrasting interactions of pipradrol, d-amphetamine, cocaine, cocaine analogues, apomorphine and other drugs with conditioned reinforcementT W Robbins, B A Watson, M Gaskin, et al.
Physical Chemistry Chemical Physics : PCCP|September 8, 2018
The prediction of far-infrared spectra for planetary nitrile ices using periodic density functional theory with comparison to thin film experimentsC Ennis, R Auchettl, D R T Appadoo, et al.
Journal of Biotechnology|March 31, 2015
Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapyKrishnamurthy V Nemani, Riley C Ennis, Karl E Griswold, et al.
Journal of Neurochemistry|June 1, 1995
Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brainX Khawaja, N Evans, Y Reilly, et al.
Life Sciences|August 7, 1978
Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidoneJ M Van Nueten, C Ennis, L Helsen, et al.
Diseases (Basel, Switzerland)|October 26, 2021
Empowering Melatonin Therapeutics with <i>Drosophila</i> ModelsCassandra Millet-Boureima, Caroline C Ennis, Jurnee Jamison, et al.
Journal of Cardiovascular Pharmacology|April 1, 1989
Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitorC Ennis, S E Granger, V C Middlefell, et al.
Drugs|January 1, 1972
Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspectsH D Breidahl, G C Ennis, F I Martin, et al.
Pageof 8